Cargando...
Panitumumab-Induced Paronychia: A Case Report and a Brief Review of the Literature
Panitumumab is a recombinant, fully humanized IgG2 monoclonal antibody targeting the epidermal growth factor receptor (EGFR). Panitumumab is indicated for patients with metastatic colorectal cancer with progressive refractory disease. Targeted therapies are well known to be well tolerated; however,...
Gardado en:
| Publicado en: | Skin Appendage Disord |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
S. Karger AG
2021
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7991612/ https://ncbi.nlm.nih.gov/pubmed/33796558 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000512036 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|